S E P T E M B E R 2 2 - 2 3, 2 0 1 0
 |
Participate in
the only translational science partnering meeting focused on commercially relevant next-generation medical solutions
Keynote Speakers
David H. Koch Institute Professor
Massachusetts Institute of Technology
Wednesday, September 22, 5:15 PM
"The Future of Regenerative Medicine, Tissue Engineering & Controlled Drug Delivery"
Former CEO
OSI Pharmaceuticals, Inc.
Wednesday, September 22, 12:00 PM
"From Bench to Bedside: The Story of OSI Pharmaceuticals"
Plenary Sessions
Translational Science – Why is it so important to move academic innovation into therapeutic development and how can we do it better?
Wednesday, September 22, 8:15 AM
• Kenneth Kaushansky, MD, MACP, Stony Brook University
• Lesa Mitchell, Ewing Marion Kauffman Foundation
• Todd Sherer, PhD, Michael J. Fox Foundation for Parkinson's Research
• Gregory C. Simon, JD, Pfizer Inc.
• Barbara S. Slusher, PhD, MBA, Brain Science Institute, Johns Hopkins School of Medicine
Working with the Biopharmaceutical Industry: Industry's changing view of early stage research and new and emerging collaboration models.
Thursday, September 23, 12:00 PM
• Greg Wiederrecht, PhD, Merck & Co., Inc.
• Robert A. Zivin, PhD, Johnson & Johnson
• Katherine Breedis, CFA, CMT, Eli Lilly & Company
Rock Stars of Science™ Campaign
Thursday, September 23, 11:15 AM
Moderator: Meryl Comer
President, Geoffrey Beene Gives Back© Alzheimer's Initiative
• Dale Schenk, PhD, Executive Vice President, Chief Scientific Officer, Elan Corporation
• Rudolph Tanzi, PhD, Director, Genetics and Aging Research Unit, MGH Institute for Neurodegenerative Disease
The Life Sciences Summit brings together key industry executives, innovators, emerging company CEOs, leading academic scientists, and early-stage investors to explore new technologies and product candidates for the treatment and diagnosis of human disease.
|
|
|||||
This unique event showcases significant and commercially relevant scientific advances, as well as introducing dynamic emerging companies seeking corporate partnerships and investment.
 |
 |
 |
 |
| Samuel J. Stanley, Jr., MD, President, Stony Brook University | Tamar Howson, MS, MBA, Partner, JSB Partners | Sharon Mates, PhD, Founder, Chairman and CEO, Intra-Cellular Therapies, Inc. | Donald L. Drakeman, JD, PhD, Venture Partner, Advent Ventures |
 |
 |
 |
 |
| Christopher Yochim, Director External Realtions Corporate Business Development, AstraZeneca Pharmaceuticals LP | Deborah A. Somerville, Partner, Kenyon & Kenyon, LLP | Susan Froshauer, PhD, President and CEO, Rib-X Pharmaceuticals, Inc. | Brock Reeve, MPhil, MBA, Executive Director, Harvard Stem Cell Institute |
| + more photos | |||